ORAI1 and prostate carcinoma: At the same time, the expression of ORAI1 reduced in prostate cancer when compared with normal and hyperplasia tissues and when the cancer progressed from low to high Gleason scores (Fig. 1D), indicating the prohibitive effect of ORAI1 on development of prostate cancer.